FALCONI, MASSIMO
 Distribuzione geografica
Continente #
AS - Asia 14.658
NA - Nord America 9.484
EU - Europa 7.313
SA - Sud America 3.979
AF - Africa 278
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 11
Totale 35.748
Nazione #
US - Stati Uniti d'America 8.991
SG - Singapore 6.407
CN - Cina 3.808
BR - Brasile 3.347
HK - Hong Kong 2.264
SE - Svezia 1.876
IT - Italia 1.664
VN - Vietnam 1.027
RU - Federazione Russa 854
DE - Germania 748
GB - Regno Unito 410
FI - Finlandia 368
IN - India 301
RO - Romania 284
AR - Argentina 257
CA - Canada 232
AT - Austria 183
IE - Irlanda 178
MX - Messico 178
PL - Polonia 155
NL - Olanda 147
BD - Bangladesh 136
FR - Francia 132
JP - Giappone 130
ZA - Sudafrica 127
EC - Ecuador 115
ID - Indonesia 111
ES - Italia 106
TR - Turchia 91
IQ - Iraq 77
CO - Colombia 68
UA - Ucraina 60
PY - Paraguay 51
LT - Lituania 47
PK - Pakistan 45
MA - Marocco 39
VE - Venezuela 38
PE - Perù 35
CL - Cile 33
TN - Tunisia 30
UZ - Uzbekistan 30
NP - Nepal 29
UY - Uruguay 26
EG - Egitto 25
IR - Iran 24
KE - Kenya 21
AE - Emirati Arabi Uniti 20
BE - Belgio 20
IL - Israele 20
AU - Australia 17
JM - Giamaica 16
SA - Arabia Saudita 16
TW - Taiwan 16
CH - Svizzera 13
DO - Repubblica Dominicana 12
DZ - Algeria 12
KZ - Kazakistan 11
CR - Costa Rica 10
JO - Giordania 10
PT - Portogallo 10
HN - Honduras 9
OM - Oman 9
RS - Serbia 9
AL - Albania 8
BH - Bahrain 8
GT - Guatemala 8
KR - Corea 8
LB - Libano 8
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
EU - Europa 6
MY - Malesia 6
PA - Panama 6
PH - Filippine 6
BG - Bulgaria 5
BO - Bolivia 5
GR - Grecia 5
KG - Kirghizistan 5
KW - Kuwait 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
GE - Georgia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
BB - Barbados 3
DM - Dominica 3
GY - Guiana 3
HU - Ungheria 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
TG - Togo 3
TH - Thailandia 3
AM - Armenia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
KH - Cambogia 2
Totale 35.705
Città #
Singapore 2.812
Hong Kong 2.250
Dallas 2.218
Ashburn 1.313
Shanghai 972
Hefei 881
Lawrence 592
Princeton 584
Beijing 514
Milan 486
New York 467
Ho Chi Minh City 374
Los Angeles 339
São Paulo 330
Moscow 263
Boardman 203
Hanoi 203
Nuremberg 201
Munich 198
Helsinki 185
Dublin 178
London 157
Rome 136
Warsaw 128
Rio de Janeiro 117
Tokyo 112
Turku 96
Orem 94
Montreal 93
Washington 93
Denver 91
Poplar 90
Pune 88
The Dalles 88
Brooklyn 87
Santa Clara 85
Lappeenranta 83
Vienna 82
Stockholm 81
Johannesburg 80
Chennai 75
Belo Horizonte 73
Atlanta 72
Phoenix 67
Seattle 65
Columbus 64
Chicago 61
Brasília 59
Guangzhou 59
Cesano Boscone 58
Frankfurt am Main 57
Mexico City 56
Houston 52
Ankara 50
Boston 48
San Francisco 46
Toronto 44
Campinas 43
Amsterdam 42
Biên Hòa 41
Curitiba 41
Porto Alegre 40
Manchester 39
Da Nang 38
Guarulhos 37
Council Bluffs 35
Guayaquil 35
Quito 35
Baghdad 33
Haiphong 33
Salvador 33
St Petersburg 33
Landshut 32
Shenzhen 31
Tianjin 31
Mumbai 30
Naples 30
Thái Bình 30
Hangzhou 29
Santo André 29
Dhaka 28
Turin 28
Ribeirão Preto 27
Tashkent 26
Falkenstein 25
Hải Dương 24
Querétaro 24
Brescia 23
Buenos Aires 23
San Jose 23
Assago 22
Cape Town 22
Changsha 22
Goiânia 22
Jakarta 22
Contagem 21
Florence 21
Fortaleza 20
Montevideo 20
Brussels 19
Totale 19.712
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 322
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes 218
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN) 155
Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk 145
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3 126
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 122
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 118
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 117
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 115
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 115
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 113
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 110
A delphic consensus assessment: Imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management 106
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial 105
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma 104
A multimodality test to guide the management of patients with a pancreatic cyst 100
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 95
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 95
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 94
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 93
A preoperative score to predict early death after pancreatic cancer resection 92
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 92
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 91
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 90
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 88
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 88
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 88
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 87
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 85
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 85
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 85
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 84
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy 84
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 83
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX 82
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 82
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility 81
Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) 81
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 81
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 81
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial 80
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 79
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 78
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts. 78
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 77
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 76
ASO Author Reflections: The Impact of CT-assessed Liver Steatosis on Postoperative Complications after Pancreaticoduodenectomy for Cancer 76
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 76
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 76
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 76
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 76
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 76
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 75
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma 75
Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study 75
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 74
ASO Visual Abstract: Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next-Generation Sequencing 74
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 74
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 73
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 72
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 72
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 72
Modelling centralization of pancreatic surgery in a nationwide analysis 72
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 72
Recovery of health-related quality of life after laparoscopic versus open distal pancreatectomy 71
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 71
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients 71
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 71
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 71
Evolving pancreatic cancer treatment: From diagnosis to healthcare management 71
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 70
Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial 70
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 70
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 70
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 70
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 70
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 69
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 68
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 68
European evidence-based guidelines on pancreatic cystic neoplasms 68
Correction to: Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 (Updates in Surgery, (2023), 75, 6, (1439-1456), 10.1007/s13304-023-01592-7) 68
A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive techniqueand variability of perioperative pathways 68
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 67
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 67
Autologous Pancreatic Islet Cell Transplantation Following Pancreatectomy for Pancreas Diseases Other Than Chronic Pancreatitis: A 15-Y Study of the Milan Protocol 67
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 67
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 67
The impact of preoperative anemia on pancreatic resection outcomes 67
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 67
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 67
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival 67
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 66
Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer 66
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 66
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 66
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 66
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 66
Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy 66
Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies 66
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 66
Totale 8.534
Categoria #
all - tutte 293.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 293.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 57 28 2 3 0 0 0
2021/2022307 0 2 21 123 31 15 16 9 21 17 9 43
2022/20233.706 1.329 743 218 48 39 397 325 325 167 32 34 49
2023/20242.648 70 132 296 250 249 555 74 268 43 105 189 417
2024/202512.216 1.365 326 326 364 425 1.064 1.795 1.006 2.053 1.594 893 1.005
2025/202617.543 2.730 3.035 2.755 5.243 2.859 921 0 0 0 0 0 0
Totale 36.634